DA Davidson Maintains Neutral on Usana Health Sciences, Lowers Price Target to $35
Portfolio Pulse from Benzinga Newsdesk
DA Davidson analyst Linda Bolton Weiser maintains a Neutral rating on Usana Health Sciences (NYSE:USNA) and lowers the price target from $38 to $35.
October 23, 2024 | 10:41 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
DA Davidson has maintained a Neutral rating on Usana Health Sciences and reduced the price target from $38 to $35, indicating a cautious outlook.
The lowering of the price target from $38 to $35 by DA Davidson suggests a less optimistic view on Usana Health Sciences' future performance, which could lead to a short-term negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100